标题
The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
作者
关键词
-
出版物
Food & Function
Volume 9, Issue 5, Pages 3018-3027
出版商
Royal Society of Chemistry (RSC)
发表日期
2018-04-19
DOI
10.1039/c8fo00033f
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
- (2017) Avi Ashkenazi et al. NATURE REVIEWS DRUG DISCOVERY
- Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense
- (2017) Ya Gao et al. Oncotarget
- Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane
- (2016) Katelyn L. O'Neill et al. GENES & DEVELOPMENT
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase
- (2016) Xiaoyu Zeng et al. Oncotarget
- Novel small molecule 11β-HSD1 inhibitor from the endophytic fungus Penicillium commune
- (2016) Weiguang Sun et al. Scientific Reports
- The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers
- (2016) Abdulraheem Alshareef et al. Scientific Reports
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- An interconnected hierarchical model of cell death regulation by the BCL-2 family
- (2015) Hui-Chen Chen et al. NATURE CELL BIOLOGY
- Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
- (2015) Joel D. Leverson et al. Science Translational Medicine
- Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax and show no preference for Bak versus Bax
- (2015) C Hockings et al. Cell Death & Disease
- Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer
- (2014) A Zeuner et al. CELL DEATH AND DIFFERENTIATION
- Targeting BCL2 for the Treatment of Lymphoid Malignancies
- (2014) Mary Ann Anderson et al. SEMINARS IN HEMATOLOGY
- Many players in BCL-2 family affairs
- (2014) Tudor Moldoveanu et al. TRENDS IN BIOCHEMICAL SCIENCES
- miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death
- (2013) Zhiyu Chen et al. Molecular Cancer
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- BCL-2 Inhibitor Yields High Response in CLL and SLL
- (2013) Cancer Discovery
- Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
- (2012) Heidi L. Perez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Navitoclax Enhances the Efficacy of Taxanes in Non–Small Cell Lung Cancer Models
- (2011) Nguyen Tan et al. CLINICAL CANCER RESEARCH
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- BH3-only proteins: Orchestrators of apoptosis
- (2010) Aisha Shamas-Din et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
- (2010) Bonsu Ku et al. CELL RESEARCH
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation